Ginkgo Bioworks Holdings, Inc.
Status: Publicly traded
Direct answer
Ginkgo Bioworks Holdings, Inc. is publicly traded on NYSE under the ticker DNA.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence...
Can you invest in Ginkgo Bioworks Holdings, Inc.?
Yes. Ginkgo Bioworks Holdings, Inc. is publicly traded on NYSE under the ticker DNA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ginkgo Bioworks Holdings, Inc.
Detailed equity research is provided by MarketSnap.